Allianz Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,470
Closed -$282K 2087
2022
Q2
$282K Sell
20,470
-7,800
-28% -$93K ﹤0.01% 2024
2022
Q1
$449K Sell
28,270
-9,862
-26% -$170K ﹤0.01% 2139
2021
Q4
$841K Sell
38,132
-13,775
-27% -$376K ﹤0.01% 1973
2021
Q3
$1.55M Buy
51,907
+275
+0.5% +$10K ﹤0.01% 1747
2021
Q2
$2.29M Sell
51,632
-56,194
-52% -$2.44M ﹤0.01% 1417
2021
Q1
$4.78M Buy
107,826
+23,449
+28% +$1.29M ﹤0.01% 1097
2020
Q4
$4.63M Sell
84,377
-259
-0.3% -$9.44K ﹤0.01% 1067
2020
Q3
$1.93M Sell
84,636
-8,487
-9% -$209K ﹤0.01% 1276
2020
Q2
$1.95M Buy
93,123
+29,873
+47% +$539K ﹤0.01% 1611
2020
Q1
$882K Buy
63,250
+11,462
+22% +$227K ﹤0.01% 1847
2019
Q4
$1.18M Sell
51,788
-37,511
-42% -$626K ﹤0.01% 2115
2019
Q3
$1.04M Buy
+89,299
New +$1.11M ﹤0.01% 2116

Other funds holding RCKT